文献速递急性肾损伤

PAK4与缺血性急性肾损伤:小鼠和人类研究

p21-Activated Kinase 4 and Ischemic Acute Kidney Injury in Mice and Humans.
PubMed 文献 · J Am Soc Nephrol · 2025-02-28

该研究探讨p21激活激酶4(PAK4)在肾脏缺血再灌注损伤中的作用。小鼠近端小管特异性敲除PAK4或使用PAK4 PROTAC可减轻缺血再灌注导致的急性肾损伤,机制涉及PAK4磷酸化并降解GPx3。在人类移植肾组织中,PAK4表达与肾功能呈负相关。

要点

  • 近端小管PAK4缺失或PROTAC降解可减轻小鼠缺血再灌注急性肾损伤。
  • PAK4通过磷酸化GPx3 T47促进其蛋白酶体降解,加剧氧化应激。
  • 移植肾组织中PAK4升高且GPx3 T47磷酸化增加,与肾功能负相关。

核心结论

  • 肾小管PAK4在缺血再灌注损伤中促进组织损伤,而PAK4 PROTAC通过减少氧化应激和促进脂肪酸β氧化来减轻损伤。

研究设计与样本

  • 野生型和近端小管特异性Pak4敲除小鼠经历25分钟缺血再灌注24小时。
  • 原代肾小管细胞和人肾-2细胞暴露于缺氧-复氧损伤以研究PAK4的体外效应。
  • 使用蛋白水解靶向嵌合体(PROTAC)选择性降解PAK4以改善AKI。

主要发现

  • 缺血再灌注后小鼠肾脏中PAK4表达通过缺氧诱导因子1α上调。
  • 近端小管细胞而非髓系细胞中PAK4缺失显著减轻缺血再灌注诱导的AKI,表现为BUN、肌酐、肾小管坏死、凋亡、巨噬细胞浸润和脂质积累水平降低。
  • PAK4在T47位点磷酸化GPx3,导致其蛋白酶体降解。
  • 用PAK4 PROTAC预处理小鼠可保留GPx3并增强脂肪酸β氧化,从而预防AKI。
  • 在人类移植肾组织中观察到PAK4蛋白和GPx3 T47磷酸化水平升高。

临床怎么用

  • PAK4可能作为缺血性急性肾损伤的潜在治疗靶点。
  • PAK4 PROTAC策略在临床前模型中显示出保护作用,但尚未在人体验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: p21-activated kinase 4 (PAK4) phosphorylates and inactivates GSH peroxidase 3 in the kidney after ischemia-reperfusion. Mice lacking PAK4 or treated with PAK4 proteolysis-targeting chimera were protected from kidney damage caused by ischemia-reperfusion injury. PAK4 expression in kidney tissues post-transplant inversely correlated with kidney function. BACKGROUND: AKI after ischemia-reperfusion remains a substantial perioperative challenge lacking effective treatment. p21-activated kinase 4 (PAK4), a downstream effector of Rho GTPase, has been explored in hepatic ischemia-reperfusion injury, but its role in renal ischemia-reperfusion is unknown. METHODS: Wild-type and proximal tubule–specific Pak4 knockout mice underwent 25 minutes of ischemia followed by 24 hours of reperfusion injury. Primary tubular cells and human kidney-2 cells were exposed to hypoxia-reoxygenation injury to investigate the in vitro effect of PAK4. Selective degradation of PAK4 was employed using proteolysis-targeting chimera (PROTAC) to ameliorate AKI. RESULTS: Post–ischemia-reperfusion, the expression of PAK4 was upregulated through hypoxia-inducible factor 1 α in mouse kidneys. Deletion of PAK4 in proximal tubule cells, but not in myeloid cells, significantly mitigated ischemia-reperfusion–induced AKI, as evidenced by decreased levels of BUN, creatinine, tubular necrosis, apoptosis, macrophage infiltration, and lipid accumulation compared with control mice. Further investigation revealed that PAK4 phosphorylated GSH peroxidase 3 (GPx3) at T47, leading to its proteasomal degradation. In addition, pretreatment of mice with the PAK4 PROTAC preserved GPx3 and enhanced fatty acid β-oxidation, thereby protecting against AKI. In kidney tissues from people with a kidney transplant, elevated levels of PAK4 protein and phosphorylation of GPx3 at T47 were observed. CONCLUSIONS: Renal tubular PAK4 contributes to tissue damage during ischemia-reperfusion injury, whereas PAK4 PROTAC mitigates ischemia-reperfusion injury by reducing oxidative stress and promoting fatty acid β-oxidation.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Yu HC, Chung BH, Kim Y, et al. p21-Activated Kinase 4 and Ischemic Acute Kidney Injury in Mice and Humans. J Am Soc Nephrol. 2025. PMID: 40019790. doi:10.1681/ASN.0000000649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。